`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
`Petitioner,
`v.
`
`GENENTECH, INC.
`Patent Owner.
`
`U.S. Patent No. 6,407,213
`
`Inter Partes Review No. IPR2017-02031
`
`PETITIONER’S REQUEST FOR ADVERSE JUDGMENT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to the Board’s authorization provided via email on July 23, 2018,
`
`Petitioner Boehringer Ingelheim Pharmaceuticals, Inc. requests termination of and
`
`adverse judgment in IPR2017-02031. Patent Owner has indicated that it does not
`
`oppose this request.
`
`Dated: July 24, 2018
`
`/Ira J. Levy/
`Ira J. Levy
`Reg. No. 35,587
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`T: (212) 813-8800
`Fax: (212) 355-3333
`ILevy@goodwinlaw.com
`
`Brian A. Fairchild
`(Reg. No. 48,645)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`T: (617) 570-1000
`Fax: (617) 523-1231
`bfairchild@goodwinlaw.com
`
`Counsel for Petitioner
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that on this
`
`24th day of July, 2018, a copy of this PETITIONER’S REQUEST FOR
`
`ADVERSE JUDGMENT was served by email on the lead and back up counsel for
`
`Patent Owners at:
`
`David Cavanaugh (David.Cavanaugh@wilmerhale.com)
`
`Lauren Blakely (Lauren.Blakely@wilmerhale.com)
`
`Adam Brausa (abrausa@durietangri.com)
`
`Robert Gunther (Robert.Gunther@wilmerhale.com)
`
`Daralyn Durie (ddurie@durietangri.com)
`
`Lisa Pirozzolo (Lisa.Pirozzolo@wilmerhale.com)
`
`Kevin Prussia (Kevin.Prussia@wilmerhale.com)
`
`Andrew Danford (Andrew.Danford@wilmerhale.com)
`
`
`
`Dated: July 24, 2018
`
`
`
`
`
`
`
`
`
`
`
`
` /Sarah Fink/
`Sarah Fink
`
`2
`
`